Clinical Trial Update: Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair

View source ↗

Summary

The Zenapro Hybrid Hernia Repair Device for ventral hernia repair has completed its clinical trial (NCT01784822) sponsored by Cook Group Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventral Hernia

Drugs mentioned

• Zenapro Hybrid Hernia Repair Device

Snippet

Sponsor: Cook Group Incorporated | Conditions: Ventral Hernias | Status: COMPLETED